MYLUNG CONSORTIUM Trademark
MYLUNG CONSORTIUM is a USPTO trademark filed by McKesson Corporation. Status: Registered.
Trademark Facts
| Mark | MYLUNG CONSORTIUM |
|---|---|
| Serial Number | 90508673 |
| Registration Number | 6777452 |
| Status | Registered |
| Filing Date | 2021-02-03 |
| Registration Date | 2022-07-05 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 035 (Advertising & Business), 042 (Software & IT), 044 (Medical Services) |
| Owner | McKesson Corporation |
| Attorney of Record | Auma N. Reggy |
| Prosecution Events | 26 |
| Latest Event | NRCC on 2022-07-05 |
Goods & Services
Class 009: Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures featuring information on research, testing, diagnosis, and treatment for lung cancer; Class 035: Business management, business administration, and office function services in the nature of the facilitation and management of the collection, tracking, and maintenance of data relating to the testing, diagnosis, and treatment of lung cancer from medical providers, patients, medical researchers, and medical, biopharmaceutical, and biotechnology companies; business administration and office function services in the nature of the coordinating the collection, compilation, tracking, and maintenance of information and data relating to the testing, diagnosis, and treatment of lung cancer; Market intelligence services, namely, providing therapeutic insights and benchmarking information to stakeholders in the fields of medicine and healthcare; Promoting collaboration within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Promoting the exchange of information within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Providing information for the development of best practices for the testing, diagnosis, and treatment of lung cancer; Class 042: Research services, namely, organizing collaborative research and development of protocols regarding the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing collaboration in medical research and data collection around the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing genomic, medical, biomedical and health care related research regarding lung cancer for medical research purposes; Providing medical research information in the field of lung cancer; Providing medical and scientific research information in the field of lung cancer; Class 044: Healthcare services, namely, collection of data and information on research, testing, diagnosis, and treatment of lung cancer for treatment and diagnostic purposes; Providing medical informational services for the purpose of raising awareness, and disseminating best practices for the testing, diagnosis, and treatment of lung cancer